C Roy

Paris Diderot University, Lutetia Parisorum, Île-de-France, France

Are you C Roy?

Claim your profile

Publications (179)310.55 Total impact

  • Feuillets de Radiologie 11/2014; · 0.17 Impact Factor
  • Feuillets de Radiologie 11/2014; · 0.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: (i) evaluate carotid artery strain derived from speckle tracking ultrasound imaging (CAS) in subjects with coronary artery disease (CAD) and without coronary artery disease (N-CAD), (ii) compare CAS, to global aortic stiffness using carotid-femoral pulse wave velocity (c-f PWV) and to endothelial function using brachial flow-mediated dilatation (FMD) in subjects with CAD.
    Cardiovascular Research 07/2014; 103(suppl 1):S141. · 5.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Previous studies reported that anti-CCP antibody positivity predicts good response to rituximab (RTX) in rheumatoid arthritis (RA). A quantitative approach to such possibility could be a good way to detect the subset of patients most likely to respond. We investigated whether serum anti-CCP antibody titres could predict response to RTX in RA patients.
    Joint, bone, spine: revue du rhumatisme 07/2014; · 2.25 Impact Factor
  • European heart journal cardiovascular Imaging. 05/2014; 15 Suppl 1:i12-i33.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Thanks to a simultaneous acquisition at high and low kilovoltage, dual energy computed tomography (DECT) can achieve material-based decomposition (iodine, water, calcium, etc.) and reconstruct images at different energy levels (40 to 140keV). Post-processing uses this potential to maximise iodine detection, which elicits demonstrated added value for chest imaging in acute and chronic embolic diseases (increases the quality of the examination and identifies perfusion defects), follow-up of aortic endografts and detection of contrast uptake in oncology. In CT angiography, these unique features are taken advantage of to reduce the iodine load by more than half. This review article aims to set out the physical basis for the technology, the acquisition and post-processing protocols used, its proven advantages in chest pathologies, and to present future developments.
    Diagnostic and interventional imaging. 04/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: La transplantation pulmonaire s’est imposée depuis la fin des années 1980 comme une option thérapeutique valable pour certains patients atteints d’une pathologie pulmonaire avancée non néoplasique. Toutefois, la survie à long terme des greffés pulmonaires reste inférieure à celle des patients ayant bénéficié d’autres types de transplantation, et ce en raison de complications postopératoires spécifiques nombreuses. Grâce au couple radiographie/scanner thoracique, le radiologue va pouvoir orienter le clinicien, en se fondant particulièrement sur le délai entre la survenue des lésions et la date de la transplantation. Seront ainsi détaillées dans cette revue iconographique les complications chirurgicales immédiates et retardées, les complications immunologiques, les complications infectieuses et les complications tardives autres.
    Journal de Radiologie Diagnostique et Interventionnelle. 04/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Grâce à une acquisition simultanée à haut et bas kilovoltage, la tomodensitométrie double énergie (TDE) permet de séparer les matériaux (iode, eau, calcium…) et de reconstruire des images à différents niveaux d’énergie (40 à 140 keV). Le post-traitement exploite ces possibilités et maximise la détection de l’iode, avec en imagerie thoracique un intérêt démontré dans la pathologie embolique aiguë et chronique (augmentation de la qualité de l’examen et identification des défects de perfusion), le suivi des endoprothèses aortiques et la détection des prises de contraste en oncologie. En angioscanographie, ces particularités sont mises à profit pour réduire de plus de moitié la dose d’iode injectée. Les objectifs de cette mise au point sont d’expliciter les bases physiques, protocoles d’acquisition et post-traitements utilisés en TDE, d’exposer ses avantages démontrés en pathologie thoracique et d’en présenter les développements à venir.
    Journal de Radiologie Diagnostique et Interventionnelle. 04/2014;
  • Source
    Dataset: Halcox 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Elevated C-reactive protein (CRP) levels are associated with high cardiovascular risk, and might identify patients who could benefit from more carefully adapted risk factor management. We have assessed the prevalence of elevated CRP levels in patients with one or more traditional cardiovascular risk factors. Data were analysed from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA, ClinicalTrials.gov Identifier: NCT00882336), which included patients (aged >=50 years) from 12 European countries with at least one traditional cardiovascular risk factor but no history of cardiovascular disease. Analysis was also carried out on the subset of patients without diabetes mellitus who were not receiving statin therapy. In the overall population, CRP levels were positively correlated with body mass index and glycated haemoglobin levels, and were negatively correlated with high-density lipoprotein cholesterol levels. CRP levels were also higher in women, those at higher traditionally estimated cardiovascular risk and those with greater numbers of metabolic syndrome markers. Among patients without diabetes mellitus who were not receiving statin therapy, approximately 30% had CRP levels >=3 mg/L, and approximately 50% had CRP levels >=2 mg/L, including those at intermediate levels of traditionally estimated cardiovascular risk. CRP levels are elevated in a large proportion of patients with at least one cardiovascular risk factor, without diabetes mellitus who are not receiving statin therapy, suggesting a higher level of cardiovascular risk than predicted according to conventional risk estimation systems. Trial registration: ClinicalTrials.gov Identifier: NCT00882336.
    BMC Cardiovascular Disorders 02/2014; 14(1):25. · 1.46 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective Previous studies reported that anti-CCP antibody positivity predicts good response to rituximab (RTX) in rheumatoid arthritis (RA). A quantitative approach to such possibility could be a good way to detect the subset of patients most likely to respond. We investigated whether serum anti-CCP antibody titres could predict response to RTX in RA patients. Methods We retrospectively investigated RA patients who received RTX. The primary criterion was decrease in DAS28 > 1.2 at 6 months (M6). Secondary efficacy criteria included a good response and remission according to EULAR. Predictors of response were investigated by multivariate logistic regression analysis. Results We included 114 RA patients (81.6% female, median age 53.5 [IQR 45.7–61.2] years, median disease duration 8.5 [4.0–16.0] years). Anti-CCP antibodies were present in 93 patients (81.6%), with median anti-CCP antibody titres 583 [195–1509] U/mL. In all, 44 patients (38.6%) showed decreased DAS28 > 1.2 at M6. On univariate analysis, high anti-CCP titres were associated with response rather than non-response to RTX (median 1122 [355–1755] vs. 386 [149–800] U/mL, P = 0.0191) at M6. On multivariate regression analysis, with a cut-off of 1000 U/mL, anti-CCP antibody titres ≥ 1000 was associated with a decrease in DAS28 > 1.2 (OR 5.10 [1.97–13.2], P = 0.0002); a EULAR good response (4.26 [1.52–11.95], P = 0.0059); and a trend for EULAR remission (2.52 [0.78–8.12], P = 0.1207). Conclusion High anti-CCP antibody titres predict response to RTX in RA. This factor, easily assessed in clinical practice, can help with personalized medicine and selecting the best candidates for RTX treatment.
    Joint Bone Spine. 01/2014;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Since the late 1980s, lung transplantation has emerged as a valid treatment option for some patients with advanced non-neoplastic lung disease. Long-term survival of lung transplant recipients, however, is lower than that of patients with other types of transplantation, because of numerous specific postoperative complications. Thanks to X-ray and CT, radiologists can guide clinicians, helped in this diagnostic approach by the time between the date of injury and date of transplantation. We will detail in this pictorial review the immediate and late surgical complications, the immunological complications, the infectious complications and other late complications.
    Diagnostic and Interventional Imaging. 01/2014;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose:Because diagnosis of Marfan syndrome is difficult during infancy, we used a large cohort of children to describe the evolution of the Marfan syndrome phenotype with age.Methods:Two hundred and fifty-nine children carrying an FBN1 gene mutation and fulfilling Ghent criteria were compared with 474 non-Marfan syndrome children.Results:Prevalence of skeletal features changed with aging: prevalence of pectus deformity increased from 43% at 0-6 years to 62% at 15-17 years, wrist signs increased from 28 to 67%, and scoliosis increased from 16 to 59%. Hypermobility decreased from 67 to 47% and pes planus decreased from 73 to 65%. Striae increased from 2 to 84%. Prevalence of ectopia lentis remained stable, varying from 66 to 72%, similar to aortic root dilatation (varying from 75 to 80%). Aortic root dilatation remained stable during follow-up in this population receiving β-blocker therapy. When comparing Marfan syndrome children with non-Marfan syndrome children, height appeared to be a simple and discriminant criterion when it was >3.3 SD above the mean. Ectopia lentis and aortic dilatation were both similarly discriminating.Conclusion:Ectopia lentis and aortic dilatation are the best-discriminating features, but height remains a simple discriminating variable for general practitioners when >3.3 SD above the mean. Mean aortic dilatation remains stable in infancy when children receive a β-blocker.Genet Med advance online publication 5 September 2013Genetics in Medicine (2013); doi:10.1038/gim.2013.123.
    Genetics in medicine: official journal of the American College of Medical Genetics 09/2013; · 3.92 Impact Factor
  • Journal de Radiologie Diagnostique et Interventionnelle. 04/2013; 94(4):479–481.
  • Source
    Diagnostic and interventional imaging. 03/2013;
  • [Show abstract] [Hide abstract]
    ABSTRACT: AIM: To describe the appearance of small solid renal lesions (≤3 cm) on diffusion-weighted magnetic resonance imaging (MRI) and to determine whether ADC measurements may help to differentiate benign from malignant small solid renal masses. METHODS AND MATERIALS: Thirty-five patients with 47 small renal masses (23 malignant, 24 benign) who underwent 3 T MRI of the kidney using diffusion-weighted sequences (b values of 0 and 1000 s/mm2) were retrospectively evaluated. Qualitative and quantitative analysis of diffusion-weighted images was performed. RESULTS: Most lesions were hyperintense to kidney on high b-value diffusion-weighted images and hypointense on apparent diffusion coefficient (ADC) map. The mean ADC of the lesions was significantly lower than that of kidney (1.22 ± 0.3 versus 1.85 ± 0.12 mm2/s; p < 0.005). The mean ADC was significantly different between renal cell carcinomas (1.2 ± 0.01 mm2/s), metastases (1.25 ± 0.04 mm2/s), angiomyolipoma (1.07 ± 0.3 mm2/s) and oncocytomas (1.56 ± 0.08 mm2/s; p < 0.05). The mean ADC of clear cell renal cell carcinomas was significantly different from that of non-clear cell renal cell carcinomas (1.38 ± 0.34 versus 0.83 ± 0.34 mm2/s; p < 0.005). No significant difference was found between mean ADC of fat containing and minimal fat angiomyolipomas (1.06 ± 0.48 versus 1.11 ± 0.33 mm2/s). CONCLUSION: Small solid renal masses are hyperintense on high b value and have different ADC values.
    Clinical Radiology 02/2013; · 1.66 Impact Factor
  • European geriatric medicine 08/2012; 3(4):219–224. · 0.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: There is no consensus regarding indications for total hip arthroplasty (THA) in hip osteoarthritis (OA). Patients can be referred to surgeons either by a general practitioner (GP) or a rheumatologist. The aim of this study was to determine whether patients referred to orthopedic surgeons by GP and rheumatologists differed. GPs and rheumatologists were asked to include one patient suffering from hip OA for whom a consultation with a surgeon was planned to determine if THA was indicated. Surgeons' decisions were obtained by follow-up questionnaires. Univariate and then multivariate statistical analysis evaluated differences between patients referred by GPs and those referred by rheumatologists. A total of 558 patients were included. THA was prescribed in 71.6 % of patients referred by rheumatologists vs. 57.6 % of patients referred by GPs (p = 0.008). Patients referred by rheumatologists were younger (66.3 vs. 69.3 years; p = 0.006), less frequently retired (72.9 vs. 84.2 %; p = 0.007), and presented with a higher New Zealand score (54.3 vs. 48.1; p = 0.0009). On multivariate analysis, the variables related to patients referred by rheumatologists were the SF-12 mental score, the New Zealand score, and the surgeon's decision. Patients consulting a surgeon to discuss THA were more likely to be operated on when referred by a rheumatologist, which might be due to differences in the rheumatologists' and GPs' opinions on the right time to perform surgery or due to differences in the populations followed by rheumatologists and GPs, those followed by rheumatologists being younger, more active, more urban, with a greater willingness to undergo surgery.
    Clinical Rheumatology 06/2012; 31(9):1301-7. · 2.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the evolution of surgical management in a large population of patients with Marfan syndrome. This is a retrospective study of patients fulfilling the Ghent criteria for Marfan syndrome, who visited the Centre de référence national pour le syndrome de Marfan et apparentés and underwent a surgical event before or during follow-up in the centre. One thousand and ninety-seven patients with Marfan syndrome, according to international criteria, came to the clinic between 1996 and 2010. Aortic surgery was performed in 249 patients (22.7%; 20 children and 229 adults), including the Bentall procedure in 140 patients (56%) and valve-sparing surgery in 88 patients (35%); a supracoronary graft was performed in 19 patients (7.6%), usually for aortic dissection. During the past 20 years, the predominant reason for aortic surgery has switched from aortic dissection to aortic dilatation, while age at surgery has tended to increase (from 32.4 ± 11.9 years to 35.2 ± 12.4 years; P=0.075). Mitral valve surgery was performed in 61 patients (5.6%; six children and 55 adults), including 37 valvuloplasties (60.6%) and 18 mitral valve replacements (29.5%). No significant difference was observed when comparing mitral valve surgery before and after 2000. Surgery performed in patients with Marfan syndrome has switched from emergency surgery for aortic dissection to elective surgery for aortic dilatation; this is associated with surgery performed at an older age despite the indication for surgery having decreased from 60mm to 50mm. No significant evolution was observed for mitral valve surgery.
    Archives of cardiovascular diseases 02/2012; 105(2):84-90. · 0.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Optimal management, including timing of surgery, remains debated in Marfan syndrome because of a lack of data on aortic risk associated with this disease. We used our database to evaluate aortic risk associated with standardized care. Patients who fulfilled the international criteria, had not had previous aortic surgery or dissection, and came to our center at least twice were included. Aortic measurements were made with echocardiography (every 2 years); patients were given systematic β-blockade and advice about sports activities. Prophylactic aortic surgery was proposed when the maximal aortic diameter reached 50 mm. Seven hundred thirty-two patients with Marfan syndrome were followed up for a mean of 6.6 years. Five deaths and 2 dissections of the ascending aorta occurred during follow-up. Event rate (death/aortic dissection) was 0.17%/y. Risk rose with increasing aortic diameter measured within 2 years of the event: from 0.09%/y per year (95% confidence interval, 0.00-0.20) when the aortic diameter was <40 mm to 0.3% (95% confidence interval, 0.00-0.71) with diameters of 45 to 49 mm and 1.33% (95% confidence interval, 0.00-3.93) with diameters of 50 to 54 mm. The risk increased 4 times at diameters ≥50 mm. The annual risk dropped below 0.05% when the aortic diameter was <50 mm after exclusion of a neonatal patient, a woman who became pregnant against our recommendation, and a 72-year-old woman with previous myocardial infarction. Risk of sudden death or aortic dissection remains low in patients with Marfan syndrome and aortic diameter between 45 and 49 mm. Aortic diameter of 50 mm appears to be a reasonable threshold for prophylactic surgery.
    Circulation 12/2011; 125(2):226-32. · 15.20 Impact Factor

Publication Stats

1k Citations
310.55 Total Impact Points

Institutions

  • 2009–2014
    • Paris Diderot University
      Lutetia Parisorum, Île-de-France, France
    • Assistance Publique Hôpitaux de Marseille
      Marsiglia, Provence-Alpes-Côte d'Azur, France
    • Hôpital La Pitié Salpêtrière (Groupe Hospitalier "La Pitié Salpêtrière - Charles Foix")
      • Service de Rhumatologie
      Paris, Ile-de-France, France
  • 2006–2014
    • Hôpital Bichat - Claude-Bernard (Hôpitaux Universitaires Paris Nord Val de Seine)
      Lutetia Parisorum, Île-de-France, France
  • 1996–2014
    • University of Strasbourg
      Strasburg, Alsace, France
  • 2008–2012
    • Centre Hospitalier Universitaire de Dijon
      Dijon, Bourgogne, France
  • 1991–2011
    • CHRU de Strasbourg
      Strasburg, Alsace, France
  • 2009–2010
    • French Institute of Health and Medical Research
      Lutetia Parisorum, Île-de-France, France
  • 2008–2009
    • Assistance Publique – Hôpitaux de Paris
      Lutetia Parisorum, Île-de-France, France
  • 2007
    • Unité Inserm U1077
      Caen, Lower Normandy, France
  • 1993–1999
    • Hospices Civils de Lyon
      Lyons, Rhône-Alpes, France
    • Centre Hospitalier Universitaire de Nice
      Nice, Provence-Alpes-Côte d'Azur, France
  • 1988
    • Centre Hospitalier Régional d'Orléans
      Orléans, Centre, France